Exercise Facilitation of Adolescent Fear Extinction, Frontolimbic Circuitry, and Endocannabinoids

ConditionAdolescence
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-17
SponsorWayne State University

About this trial

Anxiety disorders commonly begin during adolescence, and are characterized by deficits in the ability to inhibit or extinguish pathological fear. Recent research has provided new understanding of how fear is learned and can be regulated in the adolescent brain, and how the endocannabinoid system shapes these processes; however, these advances have not yet translated into improved therapeutic outcomes for adolescents with anxiety. This study will test whether a behavioral intervention, acute exercise, can help to improve fear regulation by enhancing brain activity and endocannabinoid signaling. This line of research may ultimately lead to more effect treatments for adolescent anxiety, and to new preventive strategies for at-risk youth.

Eligibility criteria

Qualifiers

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and available for the duration of the study

14-17 years of age upon enrollment

Right-handed

Disqualifiers

Traumatic brain injury with ongoing symptoms

Sensory (e.g., hearing) or physical (e.g., motor, balance) impairment or significant developmental delay

MRI participants: MRI contraindication (e.g., braces, implants, claustrophobia)

Any condition that would contraindicate blood draws (e.g., hemophilia, sickle cell)

Trial design

Treatments tested in this trial

  • Moderate Intensity Exercise

Treatment groups

174 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Wayne State University

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator